Samantha Valle-Oseguera, PharmD

Assistant Professor

Department of Clinical Pharmacy

[email protected]

Phone: +1 559 499-6514

Fax: +1 559 499-6513

155 N Fresno St, Rm 224

UCSF Box 0613

Fresno, CA 93701

United States

Links

UCSF Profiles

Experiential Education

Educational programs

UCSF Fresno Pharmacy Program

What I do

I am an assistant clinical professor in the Department of Clinical Pharmacy, based in the UCSF Fresno Pharmacy Education Program. My clinical practice site is at Kaweah Delta Medical Center in Visalia, California, where I serve as an ambulatory care clinical pharmacist at the family medicine clinic and primary care rural clinics. In addition, I am a preceptor for Kaweah Delta's PGY2 Ambulatory Care residents and APPE pharmacy students from UCSF rotating through to the Fresno practice site.

Departmental research area

clinical research

My research expertise

interprofessional collaborations, Medicare Part D, care for underserved populations, pharmacy leadership

Clinical expertise

chronic disease state management, geriatrics

Degrees

PGY2, Ambulatory Care Residency, Boise VA Medical Center

PGY1, Pharmacy Practice Residency, Boise VA Medical Center

PharmD, University of the Pacific

BS, Biotechnology, University of California, Davis

Research keywords

Dental Records, Inappropriate Prescribing, prescription drugs, Interprofessional Relations, contracts, Professional Practice, Cooperative Behavior, pharmacists, Independent Living, Medicare Part D, Dental Care, Oral Health, Prediabetic State, Dentists, Organizational Objectives

News

Publications

Valle-Oseguera CS, Ranson CA, Tam P, Le J, Le B, Kozono M, Park J, Tam A, Chen M, Rogan EL, Patel RA. Factors Associated With a Higher Risk of Undiagnosed Prediabetes in a Community-Dwelling Medicare Population. Sr Care Pharm. 2020 Feb 01; 35(2):85-92.

Rogan EL, Ranson CA, Valle-Oseguera CS, Lee C, Gumberg A, Nagin BN, Cao W, Wang E, Trinh C, Chan K, Samra NK, Hou EW, Patel RA. Factors associated with medication-related problems in an ambulatory medicare population and the case for medication therapy management. Res Social Adm Pharm. 2020 Jun; 16(6):783-786.

Rogan EL, Ranson CA, Mori TK, Park SK, Lam HM, Legaspi JF, Tran LK, Cameros CJM, Blackburn AN, Lee ST, Valle-Oseguera CS, Pham CN, Woelfel JA, Patel RA. Exploring the Valley of Savings: Minimizing Part D Costs and Optimizing Drug Therapy Outcomes in Medicare Beneficiaries With Developmental Disability. Intellect Dev Disabil. 2019 06; 57(3):234-241.

Patel R, Zhu L, Sohal D, Lenkova E, Koshki N, Woelfel J, Ranson C, Valle-Oseguera CS, Rogan EL. Use of 2015 Beers Criteria Medications by Older Medicare Beneficiaries. Consult Pharm. 2018 Jan 01; 33(1):48-54.

Boyce EG, Vyas D, Rogan EL, Valle-Oseguera CS, O'Dell KM. Impact of tofacitinib on patient outcomes in rheumatoid arthritis - review of clinical studies. Patient Relat Outcome Meas. 2016; 7:1-12.

Valle-Oseguera C, Boyce EG. Dentists and Pharmacists: Paradigm Shifts and Interprofessional Collaborative Practice Models. J Calif Dent Assoc. 2015 Oct; 43(10):591-5.